Is hyperbaric oxygen therapy (HBOT) effective for managing chronic pain from bowel dysfunction? Many patients who struggle with gastrointestinal disorders do not respond well to conventional treatments like corticosteroids and anti-inflammatories, requiring surgery to restore digestive function. As a result, more patients are looking toward alternative healing regimens to avoid these invasive procedures. Irritable bowel disease (IBD) is a condition that affects hundreds of thousands of people living in the United States. Inflammation of the gastrointestinal system can cause some patients to develop painful symptoms such as persistent abdominal cramping, soreness, diarrhea, and fever. These problems can escalate with age and make it difficult for an individual to perform at work or maintain a healthy social life. Nearly a quarter of those living with Ulcerative Colitis undergo hospitalization and surgery for their symptoms. However, many patients who seek surgical treatment for IBD experience postoperative complications that require alternative healing regimens. Some doctors believe hyperbaric oxygen therapy (HBOT) is a practical solution for mitigating chronic pain during recovery. Scholarly circles continue to debate how effective this therapy is for treating IBD. Reviews by Rossignol (2012) and Dulai et al. (2014) attempted to quantify the response rates of patients with conditions like Crohn's disease. Findings from 36 studies indicated that HBOT improved the symptoms of over three-quarters of participants. Lancet Oncology published a 2015 study by Glover et al. that monitored the response rates of patients with radiation-induced chronic gastrointestinal dysfunction. Unlike earlier reviews, researchers could not find substantial evidence that HBOT alleviated participants' symptoms. Some doctors reconsider HBOT as a postoperative solution for post-radiotherapy.